scispace - formally typeset
Journal ArticleDOI

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

D.M. Harnois
- 01 Jan 2010 - 
- Vol. 2010, pp 233-234
About
This article is published in Yearbook of Gastroenterology.The article was published on 2010-01-01. It has received 584 citations till now. The article focuses on the topics: Hepatitis C virus.

read more

Citations
More filters

The Intersection Of Chronic Hepatitis C Infection And Cardiovascular Disease

TL;DR: It is found that, on average, treatment with at least 30 days of a statin was associated with a lower HCV viral load than that observed in those unexposed to statins, and while long-term follow up was not available, statin therapy was not associated with an increased incidence of liver injury.
Journal ArticleDOI

Amantadine inhibits cellular proliferation and induces the apoptosis of hepatocellular cancer cells in vitro.

TL;DR: The role of amantadine in suppressing proliferation and inducing apoptosis in HCC cells is emphasized, advocating its use as a novel tumor-suppressive therapeutic candidate.
Journal ArticleDOI

Treatment of hepatitis C in patients with HIV

TL;DR: 12 weeks of treatment with the pan-genotypic HCV genotype 1–4 combination tablet, a secondgeneration NS3/4A protease inhibitor, and elbasvir, an NS5A inhibitor, paved the way to expansion of HCV treatment eligibility for patients with HIV and HCV coinfection.
Journal ArticleDOI

Predicting Discontinuation of Pegylated Interferon as a Result of Lack of Efficacy in United States Veterans With Chronic Hepatitis C on Dual Therapy

TL;DR: Patient characteristics that were significant predictors of discontinuation as a result of lack of efficacy (LOE) in a national database of US veterans with genotypes 1 and 4 are identified and future work should focus on determining whether these characteristics are also predictive of triple-therapy LOE discontinuations.
References
More filters
Journal ArticleDOI

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

TL;DR: Prevalence of hepatitis C cirrhosis and its complications will continue to increase through the next decade and will mostly affect those older than 60 years of age, but wider application of antiviral treatment and better responses with new agents could significantly reduce the impact of this disease in coming years.
Related Papers (5)